BioCentury
ARTICLE | Clinical News

Amphinex: Interim Phase I/II data

January 25, 2010 8:00 AM UTC

Interim data from 7 patients in the second dose group of a dose-escalation, U.K. Phase I/II trial showed that IV Amphinex plus bleomycin chemotherapy eliminated 100% of tumors within 2-4 weeks of trea...